February 23, 2022
An expert panel discusses where bempedoic acid currently fits into the treatment of hypercholesterolemia.
February 23, 2022
What pharmacists and providers need to know to counsel patients on when discussing the use of prescription or over-the-counter fish oil supplement as treatment for dyslipidemia and hypertriglyceridemia.
February 16, 2022
Takeaways of the REDUCE-IT trial of icosapent ethyl as treatment for dyslipidemia and hypertriglyceridemia.
February 16, 2022
An overview of the REDUCE-IT trial of icosapent ethyl for the management of triglycerides and prevention of cardiovascular events.
April 04, 2021
Dr. Nisha Parikh provides additional insight into the AHA's latest scientific statement, which highlights the need for greater attention and emphasis on the impact of adverse pregnancy outcomes on cardiovascular risk in women.
February 23, 2021
An analysis of more than 2k patients from within the Look AHEAD study suggests the timing of physical activity could play a role in mitigating cardiovascular risk among men with type 2 diabetes considered overweight or obese.
February 23, 2021
An analysis of data from more than 130 women suggests hypertensive disorders of pregnancy were associated with cardiac remodeling and risk of cardiovascular disease later in life.
February 20, 2021
An analysis of more than 100 patients hospitalized with severe COVID-19 indicates subsequent heart damage was discovered in more than half of these patients in imaging more than a month after discharge.
February 04, 2021
An analysis of 29k patients with type 2 diabetes suggests increased HbA1c variability within the first 2 years of a diabetes diagnosis was associated with a 30-59% increase in risk of incident cardiovascular disease.
February 01, 2021
New research from Kaiser Permanente Northern California suggests gestational diabetes was linked to a 2-fold increase in risk of coronary artery calcification, regardless of glycemic control after giving birth.